This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Merck Sharp + Dohme Corp.. Active years: 2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2021
Title: Chuanman Huang: Innovator in Pharmaceutical Chemistry
Introduction
Chuanman Huang is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that target specific receptors in the body.
Latest Patents
Huang holds a patent for "Piperidine derivatives as liver X receptor beta agonists, compositions, and their use." This invention provides certain piperidine compounds that are useful as Liver X-β receptor (LXRβ) agonists. These compounds may be beneficial in treating or preventing various pathologies, including inflammatory diseases and conditions related to cholesterol and lipid metabolism, such as Alzheimer's disease. He has 1 patent to his name.
Career Highlights
Chuanman Huang is currently associated with Merck Sharp & Dohme Corp., where he continues to work on innovative solutions in the pharmaceutical industry. His research focuses on developing new therapeutic agents that can address significant health challenges.
Collaborations
Huang has collaborated with notable colleagues, including Zhaoyang Meng and Xuewang Xu. Their combined expertise contributes to the advancement of research and development in their field.
Conclusion
Chuanman Huang's work exemplifies the impact of innovative research in pharmaceutical chemistry. His contributions are paving the way for new treatments that could improve patient outcomes in various diseases.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile